Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients
Status:
Completed
Trial end date:
2017-05-15
Target enrollment:
Participant gender:
Summary
This mechanistic study is a single-center, randomized, double-blind, placebo-controlled,
cross-over study to evaluate the effect of dual bronchodilation with QVA149 on cardiac and
lung function parameters in hyperinflated COPD patients.